Bellevue Group’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7,879,583
|
|
||||
|
2024
Q3 | $47.8M | Sell |
7,879,583
-10,000
|
|
||||
|
2024
Q2 | $41.5M | Hold |
7,889,583
|
|
||||
|
2024
Q1 | $67M | Sell |
7,889,583
-9,000
|
|
||||
|
2023
Q4 | $52.1M | Hold |
7,898,583
|
|
||||
|
2023
Q3 | $24.4M | Hold |
7,898,583
|
|
||||
|
2023
Q2 | $21.3M | Hold |
7,898,583
|
|
||||
|
2023
Q1 | $23.5M | Hold |
7,898,583
|
|
||||
|
2022
Q4 | $19.9M | Buy |
7,898,583
+2,000,000
|
|
||||
|
2022
Q3 | $10.7M | Buy |
5,898,583
+888,869
|
|
||||
|
2022
Q2 | $15.8M | Sell |
5,009,714
-25,100
|
|
||||
|
2022
Q1 | $31.1M | Hold |
5,034,814
|
|
||||
|
2021
Q4 | $71.5M | Hold |
5,034,814
|
|
||||
|
2021
Q3 | $40.3M | Buy |
5,034,814
+2,575,000
|
|
||||
|
2021
Q2 | $70.3M | Buy |
2,459,814
+634,000
|
|
||||
|
2021
Q1 | $53M | Buy |
+1,825,814
|
|